Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy

E-ISSN： 1875-533x|10|16|1603-1615

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.16, 2003-08, pp. : 1603-1615

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

Current Drug Targets, Vol. 18, Iss. 2, 2016-12 ,pp. : 232-253

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Kappa B is a Promising Therapeutic Target in Inflammatory Lung Disease

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 661-668

Bentham Science Publishers

Access to resources Recommend Favorite

New Developments in Anti-HIV Chemotherapy

Current Medicinal Chemistry, Vol. 8, Iss. 13, 2001-11 ,pp. : 1543-1572

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear factor kappa B and hepatitis viruses

By Guan Yong-Song He Qing Wang Ming-Quan Li Ping

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 265-280

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Analysis of the Molecular Recognitions Between HIV-1 TAR-RNA and Transcription Factor Nuclear Factor-kappaB (NFkB)

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 8, 2012-04 ,pp. : 814-827

Bentham Science Publishers

Access to resources Recommend Favorite